HCL Technologies Limited has informed the Exchange regarding 'Grant of Restricted Stock Units ( RSUs )'.
HCLTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On January 8, 2026, the Nomination and Remuneration Committee of HCL Technologies approved the grant of 601 RSUs to 1 employee under the RSU Plan 2021 and 24,659 RSUs to 5 employees under the RSU Plan 2024, totalling 25,260 RSUs. This represents about 0.001% of the company's paid-up equity share capital, with each RSU convertible into one equity share of ₹2 face value. The shares will be sourced from the secondary market via a trust mechanism, so no fresh shares will be issued and there will be no dilution of earnings per share. The vesting schedule spans from January 31, 2027 to June 30, 2028, and vested RSUs must be exercised within 6 months at ₹2 per share. Separately, 23,925 previously approved RSUs under the RSU Plan 2024 were cancelled.
This is a routine employee stock incentive grant with negligible impact on shareholding (0.001%) and no EPS dilution since shares are bought from the market. The cancellation of 23,925 previously approved RSUs modestly reduces future share transfer obligations to employees. Shareholders are largely unaffected.